USFDA issues 6 observations for Zydus Lifesciences Ahmedabad facility
Ahmedabad: Zydus Lifesciences has announced that the U.S. Food and Drug Administration (USFDA) has closed the inspection with 6 observations at the Company’s API site situated at Changodar, Ahmedabad. This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023. “There were no Data Integrity related observations. There are no repeat observations from the previous […]